You have 9 free searches left this month | for more free features.

Esophagogastric Cancers

Showing 1 - 25 of 4,915

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Esophagogastric Cancer Trial in Boston (STA-9090)

Completed
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +2 more
Jul 31, 2020

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Esophagogastric Cancer Trial in Toronto (PET-MRI)

Recruiting
  • Esophagogastric Cancer
  • PET-MRI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 5, 2023

Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +3 more
  • New York, New York
  • +1 more
Jul 28, 2022

Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

Recruiting
  • Esophagogastric Tumors
  • +9 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • BMS-986213
  • +4 more
  • Clovis, California
  • +77 more
Jan 9, 2023

Metastatic Breast Cancer Trial in New York (Tucatinib)

Recruiting
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 26, 2023

Gastric Cancer Trial in Beijing (Radical gastrectomy with dissection of lower mediastinal lymph node)

Recruiting
  • Gastric Cancer
  • Radical gastrectomy with dissection of lower mediastinal lymph node
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 21, 2021

Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)

Active, not recruiting
  • Gastric Cancer
  • Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
  • +2 more
  • Newcastle, New South Wales, Australia
  • +22 more
Mar 21, 2022

Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)

Recruiting
  • Stomach Neoplasm
  • +9 more
  • Ocoxin-Viusid®
  • Havana, La Habana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Oct 20, 2021

Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Surgery
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

Not yet recruiting
  • Gastric
  • Colorectal Adenocarcinoma
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Nov 1, 2023

Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)

Not yet recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Surveillance protocol
  • Cologne, Germany
  • +12 more
Oct 29, 2023

Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

Recruiting
  • Acute Esophageal Variceal Hemorrhage
  • Growth Inhibitor
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023

Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

Not yet recruiting
  • Gastric Adenocarcinoma
  • cadonilimab combined +paclitaxel (albumin-bound)
  • (no location specified)
Nov 1, 2023

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

The Diagnostic Dilemma of Anastomotic Leak in Esophagogastric

Completed
  • Anastomotic Leak
  • Esophageal and gastric resections requiring an anastomosis
  • Singapore, Singapore
    National University Hospital
Oct 21, 2022

Anastomotic Leak Esophagus Trial (Obsidian)

Not yet recruiting
  • Anastomotic Leak Esophagus
  • Obsidian
  • (no location specified)
Feb 1, 2023

Siewert Type II Adenocarcinoma of Esophagogastric Junction Trial in Xi'an (Endoscopy Ivor-lewis, Laparoscopic transabdominal

Recruiting
  • Siewert Type II Adenocarcinoma of Esophagogastric Junction
  • Endoscopy Ivor-lewis
  • Laparoscopic transabdominal enlarged gastrectomy
  • Xi'an, Shaanxi, China
    Li
Jun 7, 2022

the Effect of Succinylcholine on Barrier Pressure Trial (Succinylcholine)

Completed
  • the Effect of Succinylcholine on Barrier Pressure
  • (no location specified)
Sep 23, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023